Understand this diagnosis through data, infographics, and evidence based on modern classification and current research.
Headache, seizures, focal neurological deficits depending on the cortical region involved.
Leg weakness (bilateral if large), seizures, and progressive motor deficits.
Cranial nerve deficits: vision changes, hearing loss, facial numbness, or double vision.
Proptosis (eye bulging), vision changes, temporal swelling, and facial pain.
Balance problems, headache, hydrocephalus, and cranial nerve palsies.
Anosmia (loss of smell), personality changes, and frontal lobe dysfunction.
Back pain, weakness, sensory changes, and bowel/bladder issues from cord compression.
Many meningiomas are incidental findings on imaging performed for other reasons (asymptomatic).
Gold standard: reveals “dural tail” sign, well-circumscribed extra-axial mass
Calcifications are common; useful complement to MRI for bone involvement
For surgical planning: identify blood supply, consider preoperative embolization
WHO grading from biopsy or surgical resection specimen
NF2, AKT1, TRAF7 analysis and DNA methylation profiling for subtype classification
Personalized plan based on grade, location, size, and molecular profile
Primary treatment. Simpson grading scale (I-V) for extent of resection. Skull base approaches for complex locations.
Post-operative for incompletely resected or higher-grade tumors. IMRT and proton therapy options available.
Gamma Knife, CyberKnife for small tumors (<3cm), residual, or recurrent meningiomas. Single fraction delivery.
For small, asymptomatic tumors. Serial MRI monitoring at regular intervals to track growth rate.
Limited role currently. Hydroxyurea, bevacizumab for refractory cases. Emerging: SMO inhibitors, CDK4/6 inhibitors, FAK inhibitors.
Access cutting-edge experimental treatments and emerging targeted therapies
Browse clinical trials →Primary specialist for surgical resection and skull base approaches
Plans and delivers radiation therapy and stereotactic radiosurgery
For higher-grade or refractory meningiomas requiring systemic therapy
Specialized imaging interpretation and monitoring
Tissue analysis, WHO grading, and molecular profiling
Guides you through appointments, insurance, and logistics
A dedicated meningioma-specific support community offering peer connection, resources, and hope for patients and families.
Visit Meningioma Mommas →Leading nonprofit investing in research, advocacy, and patient services for all brain tumors including meningioma.
Visit NBTS →Comprehensive brain tumor information, patient support programs, and research funding for all tumor types.
Visit ABTA →The world’s leading brain tumour charity, funding research and providing support and information across the UK.
Visit Brain Tumour Charity →Advanced treatment and research programs for brain tumors at leading academic medical centers.
Visit Ivy Center →Central Brain Tumor Registry of the United States — the largest population-based registry for primary brain tumors.
Visit CBTRUS →Dedicated to meningioma and brain science research, funding innovative studies and providing patient education resources.
Visit Brain Science Foundation →Supporting research and patient resources for NF2-related meningiomas and other NF2 tumors.
Visit NF2 BioSolutions →National Cancer Institute’s rare brain and spine tumor network, offering expert guidance and clinical trial information.
Visit NCI-CONNECT →